Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo advised Quaise Energy on the transaction. Quaise Energy, Inc. (“Quaise Energy”) announced it has raised $21 million Series A1 funding round...
Quaise Energy’s $21 Million Series A1 Funding Round
Tonaquint’s Acquisition of EdgeX Data Centers
Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo represented Tonaquint Data Centers in the transaction. DIF Capital Partners’ (DIF) investee company Tonaquint Data Centers (Tonaquint), a DIF Capital...
Orgenesis’ $1.1 Million Common Stock Offering
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo represented Orgenesis Inc. in the offering, and Sichenzia Ross Ference Carmel represented Titan Partners Group, an institutional investor. Orgenesis...
Topgolf Callaway’s $29 Million Acquisition of Bigshots Golf
Latham & Watkins advised Topgolf Callaway on the transaction, and Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo advised Invited, Inc. Topgolf Callaway Brands Corp. (NYSE: MODG)...
Standard BioTools’ Merger with SomaLogic
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Standard BioTools Inc. on the transaction, and Fenwick & West advised SomaLogic, Inc. Standard BioTools Inc. (Nasdaq: LAB) and SomaLogic (Nasdaq:...
Seviroli Foods’ Acquisition of Mama Rosie’s
Mintz represented Mama Rosie’s Company in the transaction. Seviroli Foods LLC (“Seviroli”) announced that it has acquired Mama Rosie’s Company, Inc. (“Mama Rosie’s” or the “Company”). The...
Hopewell Therapeutics’ $25 Million Seed Financing
Mintz advised Hopewell Therapeutics in the transaction. Hopewell Therapeutics, a biotechnology company with a differentiated lipid nanoparticle platform harnessing unique ionizable lipid chemistry, in its Seed...
Gradiant’s $225 Million Series D Financing
Mintz represented Gradiant Corporation in the transaction. Gradiant Corporation, a global end-to-end solutions provider of advanced water and wastewater treatment, closed its Series D financing. The...
Viking Therapeutics’s $287.5 Million IPO
Mintz advised the syndicate of underwriters on the deal. Viking Therapeutics, Inc. (“Viking”) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies...
ArriVent Biopharma’s $155M Series B Financing
Mintz represented ArriVent Biopharma, Inc. on the deal. ArriVent Biopharma, Inc, a Pennsylvania-based company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, announced its $155...
Diffusion Pharmaceuticals’ Merger with EIP Pharma Inc.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. advised EIP Pharma, while Dechert LLP advised Diffusion Pharmaceuticals on the deal. Diffusion Pharmaceuticals Inc. announced a proposed...
Princeton CarbonWorks’ Victory in a Patent Dispute
Mintz advised Princeton CarbonWorks, Inc. on the deal. Princeton CarbonWorks, Inc. obtained a victory before the U.S. District Court for the Southern District of Florida. The Connecticut-based...